Men, who are thinking of undergoing prostate cancer screening should not push through with their plan.

The idea that belief that finding cancer early on can do more harm than help is hard to understand.  However, it is at the heart of a government panel’s draft proposal that those PSA blood tests should no longer be part of regular screening for healthy men.

The U.S. Preventive Services Task Force looked at all the evidence and did not discover if any decrease in deaths from habitual PSA screening.  However, the results conclude most of the men who got diagnosed with tumors that never would have killed them and suffer serious consequences from resulting treatment.

That advice is not final — it is a draft open for public remark.  However, it does goes a step further than most of the cancer groups that include the American Cancer Society, urging the men be told the pros and cons and makes the decision for them.

The new suggestion is in a huge controversial.  There are some doctors, who did not approve the idea.

Prostate cancer specialist at the University of Chicago, Dr. Scott Eggener, think people all agree that we can do a better job of figuring out who would benefit from PSA screening.  However,  a blanket announcement of just doing away with it altogether … seems over-aggressive and reckless.

Cranston, R.I., internal medicine specialist who chairs the American College of Physicians’ board of regents, Dr. Yul Ejnes say the problem has been giving men a hard time for the longest time now.

According to an article written by the American Cancer Society’s Dr. Len Lichtenfeld, it is an emotional shift.

People believed that PSA testing works for 20 years now. Now, researchers just say that the past research is not that accurate. The people  poked and probed.

Too much PSA, or prostate-specific antigen, in the blood only occasionally will prove the existence of prostate cancer. It also can signify that the man needed to be treated immediately as h e would not want to suffer from that condition.

Sometime screening detects the tumor already presented in the body.  However, no one can tell in advance who needs treatment.

In the US, there’s an estimated 1 in 6 U.S. men is going to be diagnosed with prostate cancer one day. Yet the cancer society takes note that in Western European countries where the test is not  screening is not ordinary 1 in 10 men gets diagnosed, and the risk of death in both places is the same. There are an estimated of 217,000 men diagnosed with prostate cancer yearly r, and 32,000 of them die.